Investigation of Intra-Fraction Stability and Inter-Fraction Reproducibility of Deep Inspiration Breath-Hold Across Two Hypofractionated Radiotherapy Regimens in the HYPORT Adjuvant Study.

In radiotherapy for left-sided breast cancer, the proximity of the heart to the target volume creates a precarious balancing act. Clinicians must deliver a lethal dose of radiation to the tumor while minimizing "spillage" (excess radiation) that causes long-term cardiac toxicity. One effective way to achieve this is through Deep Inspiration Breath-Hold (DIBH). In this technique, the patient takes a deep breath and holds it. This physically expands the chest cavity to push the heart away from the radiation beam.

While DIBH is a standard tool, its efficacy relies on the patient's ability to replicate a specific respiratory amplitude (the height of the breath). This must be done consistently across multiple treatment sessions. If a patient breathes shallower on Tuesday than they did during their initial planning scan, the heart may drift back into the line of fire. As radiotherapy moves toward hypofractionation (delivering larger doses in fewer sessions), the margin for error shrinks. This study investigates whether newer, faster treatment schedules affect the stability and reproducibility of these breath-holds.

The challenge of respiratory motion management

The fundamental difficulty in treating breast cancer lies in the multidimensional movement of the thorax (the chest area). As a patient breathes, the breast, heart, and lungs shift in unpredictable ways. Current clinical practice uses DIBH to mitigate this, but the technique faces two distinct types of variability:

1. Intra-fraction instability: Variations in breath-hold depth that occur during a single radiation delivery. If the breath wavers while the beam is on, the target moves mid-treatment.
2. Inter-fraction reproducibility: The inability of a patient to return to the same breath-hold depth from one day to the next. If the "reference" breath-hold used for planning is not matched later, the geometric setup becomes invalid.

Existing protocols often rely on broad "gating windows" (allowable ranges of motion). If these windows are too wide, they fail to protect the heart. If they are too narrow, they cause frequent interruptions in treatment. The transition from traditional 15-fraction regimens to ultra-fast 5-fraction regimens requires a rigorous understanding of whether these motion patterns remain robust.

Quantifying the breath-hold through waveform analysis

To evaluate these dynamics, the researchers analyzed respiratory waveforms from 510 left-sided breast cancer patients in the HYPORT Adjuvant trial. The study compared two distinct regimens: a moderate-hypofractionation "control" arm (40 Gy in 15 fractions) and a one-week "experimental" arm (26 Gy in 5 fractions).

The methodology relied on the Varian Real-time Position Management (RPM) system. This system uses a camera to track retroreflective markers (small, shiny dots) placed on the patient's xiphisternum (the lower part of the breastbone). These markers serve as a surrogate for diaphragm movement. The researchers followed a structured pipeline to turn raw motion into data:

1. Training and Simulation: Before treatment, patients underwent three training sessions to master the DIBH technique. This moved the patient from a natural, free-breathing state to a controlled, high-amplitude inspiratory hold.
2. Waveform Normalization: Raw amplitude data (the vertical movement of the respiratory signal) was normalized. The researchers set the minimum point of free breathing to 0 mm. This allowed them to express all breath-holds as a relative increase in amplitude .

3. Gating Threshold Establishment: During the final training session (the simulation scan), a specific upper threshold was set. This threshold defines the "target" breath-hold position.
4. Statistical Comparison: Intra-fraction stability was measured as the standard deviation (SD) of the amplitude during the "beam-on" period. Inter-fraction reproducibility was measured as the average deviation of each daily median amplitude from the original simulation reference.

Evidence of training gains and regimen stability

The authors report that the structured training protocol was highly successful. By the final simulation session, patients in both arms showed a substantial increase in respiratory amplitude. Specifically, the experimental arm saw a 22.87% increase and the control arm saw a 23.99% increase [Table 2]. This training translated into physiological changes. Both arms demonstrated an approximate 1.7-fold increase in lung air volume during DIBH compared to free breathing.

Crucially, the study found that the two regimens achieved comparable cardiac protection. Even though the experimental arm used a different prescription dose, the mean heart dose remained similar. It was 75.6 cGy (2.91%) for the experimental arm and 118.51 cGy (2.95%) for the control arm [Table 3].

When looking at the core metrics of motion management, the results diverged:

• Intra-fraction stability was nearly identical. The median amplitude variation during beam delivery was 1.006 mm for the control arm and 1.079 mm for the experimental arm .

This suggests that once a patient holds their breath, they stay steady regardless of the total treatment length. * Inter-fraction reproducibility was superior in the experimental arm. The experimental arm had a lower mean deviation from the reference amplitude (0.44 ± 0.24 mm) compared to the control arm (0.66 ± 0.25 mm) .

When the researchers isolated the first five fractions of the control arm, the reproducibility was almost identical to the experimental arm (0.40 mm vs. 0.44 mm). This implies that the "decline" in reproducibility in the control arm happens over time. The longer the treatment course, the harder it becomes for patients to maintain perfect consistency.

Limitations and the path to tighter gating

While the findings are encouraging, the study has boundaries. First, this work is a preprint and has not undergone formal peer review. Second, the authors acknowledge that the trends in reproducibility may require further validation before changing institutional protocols.

Third, the study focuses on the mechanical stability of the breath-hold. It does not account for other potential errors. These include slight changes in patient positioning or internal anatomical shifts as tissues heal. Finally, the success of DIBH depends on initial training. The study shows that performance variance is largely driven by how differently individuals respond to coaching .

Verdict: A green light for accelerated schedules

The evidence supports the clinical reliability of the one-week hypofractionation regimen. The data shows the experimental arm is as stable during radiation delivery as the standard regimen. It is also more consistent across the entire treatment course. Because the shorter regimen avoids the gradual decay in reproducibility seen in longer treatments, it offers a more predictable environment.

Based on the observed stability, the authors suggest that clinical teams could potentially narrow the DIBH gating window. They propose moving from a 5 mm window (±3/-2 mm) to a tighter 4 mm window (±2/-2 mm). Such a refinement could allow for even more precise cardiac sparing without increasing beam interruptions. For practitioners moving toward faster radiotherapy, this study provides a robust quantitative foundation.

Figures from the paper